Delayed Graft Function clinical trials at UC Davis
1 research study open to eligible people
A Study of Experimental Medicine BB3 to Reduce the Severity of Delayed Graft Function (DGF) in Kidney Transplants
open to eligible people ages 18 years and up
The major objective is to demonstrate the safety and efficacy of ANG-3777 in improving graft function and reducing the severity of delayed graft function (DGF) in recipients at high risk of DGF after receiving a deceased donor renal allograft.
Sacramento, California and other locations